August 6, 2026 Sophia Vida
Breaking News

BioStem Technologies Announces Nasdaq Uplisting

Trading to Commence on August 7, 2026 POMPANO BEACH, Fla., August 6, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that The Nasdaq … Continue reading “BioStem Technologies Announces Nasdaq Uplisting”